On Monday, Tandem Diabetes Care Inc (NASDAQ: TNDM) opened higher 2.05% from the last session, before settling in for the closing price of $22.98. Price fluctuations for TNDM have ranged from $15.75 to $53.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 22.33%. Company’s average yearly earnings per share was noted -28.85% at the time writing. With a float of $66.06 million, this company’s outstanding shares have now reached $66.57 million.
Let’s determine the extent of company efficiency that accounts for 2650 employees. In terms of profitability, gross margin is 46.57%, operating margin of -16.18%, and the pretax margin is -15.82%.
Tandem Diabetes Care Inc (TNDM) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Tandem Diabetes Care Inc is 0.83%, while institutional ownership is 108.79%. The most recent insider transaction that took place on Mar 07 ’25, was worth 190,966. In this transaction EVP & Chief Operating Officer of this company bought 10,538 shares at a rate of $18.12, taking the stock ownership to the 10,538 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 30,000 for $31.38, making the entire transaction worth $941,400. This insider now owns 165,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -28.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 60.60% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Check out the current performance indicators for Tandem Diabetes Care Inc (TNDM). In the past quarter, the stock posted a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Looking closely at Tandem Diabetes Care Inc (NASDAQ: TNDM), its last 5-days average volume was 1.82 million, which is a jump from its year-to-date volume of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 92.38%. Additionally, its Average True Range was 1.21.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 34.18%, which indicates a significant decrease from 92.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.23% in the past 14 days, which was lower than the 87.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.92, while its 200-day Moving Average is $32.18. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $23.89. Second resistance stands at $24.34. The third major resistance level sits at $24.67. If the price goes on to break the first support level at $23.11, it is likely to go to the next support level at $22.78. Should the price break the second support level, the third support level stands at $22.33.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are currently 66,607K shares outstanding in the company with a market cap of 1.56 billion. Presently, the company’s annual sales total 940,200 K according to its annual income of -96,030 K. Last quarter, the company’s sales amounted to 234,420 K and its income totaled -130,560 K.
